Top Story

Autologous cell therapy continues to show benefit in patients with LV dysfunction after STEMI

March 27, 2015

SAN DIEGO — At 12-month follow-up, autologous CD34+ cell therapy for patients with left ventricular dysfunction after STEMI appears to be safe and may be effective, according to new data from the PreSERVE-AMI study.

The cell therapy was safe and well tolerated, showed a signal of mortality benefit and showed a signal for reduced serious adverse events in higher-dose groups.

In the Journals

New CVD risk score can be adjusted for use in any country

March 27, 2015
A new risk equation can be recalibrated for application in any country with routinely available information, researchers reported in The Lancet Diabetes &
Breaking News

Senate adjourns without voting on bill to repeal sustainable growth rate

March 27, 2015
The U.S. Senate left for its 2-week spring break without voting on a bill that repeals the sustainable growth rate, leaving physicians to face a 21% payment cut if…
Paul Sorajja, MD Meeting News CoveragePerspective

First report of US commercial data for transcatheter mitral valve repair system shows favorable outcomes

March 27, 2015
SAN DIEGO — In the first report of U.S. commercial experience with transcatheter mitral valve repair presented at American College of Cardiology Scientific…
In the Journals

Higher CV risk with acarbose than metformin in type 2 diabetes

March 27, 2015
In the nationwide cohort study, Lee-Ming Chuang, MD, PhD, of Nationwide Taiwan University Hospital, and colleagues evaluated data from the Taiwan National Health…
More News Headlines »
CME
Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent, yet modifiable, risk factor for atherosclerotic disease, pancreatitis, and…
More »
Meeting News Coverage Video
4132203130001 th

VIDEO: New IMPROVE-IT analyses reinforce benefits of greater cholesterol reduction

March 24, 2015
SAN DIEGO — In this video, Christopher P. Cannon, MD, of Brigham and Women's Hospital in Boston, discusses two…
More »
CME
Obesity Consults: Volume 2, Number 1

Obesity Consults: Volume 2, Number 1

This activity is supported by an educational grant from Vivus, Inc.

Obesity is suboptimally managed in clinical practice despite the availability of relevantguidelines and evidence-based…
More »
morganatic-roan
morganatic-roan